REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 211 filers reported holding REGENXBIO INC in Q1 2019. The put-call ratio across all filers is 1.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $13,476,000 | +37.4% | 235,148 | +0.6% | 0.02% | +14.3% |
Q4 2018 | $9,806,000 | -70.7% | 233,748 | -47.3% | 0.01% | -30.0% |
Q3 2018 | $33,518,000 | +124.1% | 443,958 | +113.0% | 0.02% | +5.3% |
Q2 2018 | $14,956,000 | +905.1% | 208,442 | +318.1% | 0.02% | +850.0% |
Q1 2018 | $1,488,000 | -10.3% | 49,857 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $1,658,000 | +0.5% | 49,857 | -0.4% | 0.00% | 0.0% |
Q3 2017 | $1,649,000 | +70.5% | 50,043 | +2.2% | 0.00% | +100.0% |
Q2 2017 | $967,000 | +41.8% | 48,957 | +38.5% | 0.00% | 0.0% |
Q1 2017 | $682,000 | +8.4% | 35,351 | +4.3% | 0.00% | 0.0% |
Q4 2016 | $629,000 | +37.0% | 33,884 | +3.4% | 0.00% | 0.0% |
Q3 2016 | $459,000 | +75.2% | 32,782 | 0.0% | 0.00% | – |
Q2 2016 | $262,000 | +201.1% | 32,782 | +307.1% | 0.00% | – |
Q1 2016 | $87,000 | -28.1% | 8,053 | +10.8% | 0.00% | – |
Q4 2015 | $121,000 | – | 7,270 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |